Ligand Pharmaceuticals LGND Senior Long Term Notes
Senior Long Term Notes at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:SeniorLongTermNotes.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's senior long term notes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ligand Pharmaceuticals's senior long term notes?
- Ligand Pharmaceuticals (LGND) reported senior long term notes of $446.9M in Q1 2026.
- What does senior long term notes mean?
- This represents the principal amount of long-term debt obligations that rank senior to other forms of indebtedness in the company's capital structure. It reflects the company's reliance on external financing to fund operations, acquisitions, or research and development. Monitoring this is vital for assessing the company's overall leverage, interest expense burden, and credit risk profile.